Replies to post #408375 on Anavex Life Sciences Corp (AVXL)

[BAR123]

This is how a baby biotech stock behaves when they have not had P3 data readouts. If you put our data in the hands of BIIB or AXSM they would have a market cap of $7-10B. Because the market respects them. In our hands the data and we the company are dog sxxx. We are at the price we are at because of Dr. Missling not doing the things that make wall st happy. Like doing deals with them. Like doing an ipo with them. He obviously knows what he has and maybe he doesn't need wall st to sell the company for $10B. But the stock price will languish until a partnership or buyout and personally I think that is a horrible way to run the company. For retail shareholders anyway.